Small Bone Innovations Inc.
CardioMEMS, Nevro among top 20 VC-backed healthcare exits of 2014
At least 4 medtech exits were significant enough to make the cut for the top 20 venture capital-backed healthcare exits of 2014, according to research firm CB Insights.
Stryker completes Small Bone Innovations buy
Stryker closes portion of $375M Small Bone Innovations buy
Stryker to pay $375M for Small Bone Innovations assets
UPDATED June 30, 2014, with comment from Small Bone Innovations founder.
Ex-KCI CEO Burzik dives into venture capital | Personnel Moves
Nevro wins FDA approval to launch spinal stimulation trial | Regulatory Roundup
Stryker ex-CEO MacMillan resigns from Texas Instruments board | Personnel Moves
Following his abrupt resignation from the corner office at Stryker Corp. (NYSE:SYK), Stephen MacMillan also stepped down from the Texas Instruments board of directors.
MacMillan had been on the board since 2008. No reason was given for his departure in regulatory filings.
SBi secures $43M loan | Funding Roundup
Star total ankle replacementOrthopedic technology company Small Bone Innovations Inc. landed a $43 million loan to further sales of its flagship ankle replacement device.
The New York-based company plans to use the credit facility as working capital to drive U.S. growth of its Star total ankle replacement, a non-cemented implant designed to replace arthritic ankle joints in patients with osteoarthritis, post-traumatic arthritis or rheumatoid arthritis.
The system is currently the only mobile-bearing total ankle replacement approved for the U.S. market.
Cellulite: Cynosure touts regulatory wins for laser fat-removal products | Regulatory roundup
Cynosure Inc. (NSDQ:CYNO) officials said the company has won international regulatory approval for two of its cellulite reduction systems, including the SmoothShapes laser liposuction device that sucked $40 million out of now-defunct Elemé Medical Inc.
FDA approves Boston Scientific’s pain management implant “anchor” | Regulatory roundup
The FDA granted Boston Scientific Corp. (NYSE:BSX) approval for its anchoring device for the company’s spinal cord stimulator (SCS) implant system.
The Natick, Mass.-based medical device giant designed its new Clik Anchor with locking system to increase the speed with which surgeons place the Precision Plus SCS system’s leads — the wires through which pain-masking electrical pulses are delivered to the spine for chronic pain management.
